#	Pagina
attuale pagina	/open-h2020/projects/206702/index.html

Opendata, web and dolomites

mR-NIPD

Proof of Concept study for ERC NIPD discovered biomarkers

Total Cost €

EC-Contrib. €

Partnership

Views

mR-NIPD project word cloud

Explore the words cloud of the mR-NIPD project. It provides you a very rough idea of what is the project "mR-NIPD" about.

invasive combined syndrome examine alternative grant mrna modern pregnancy social accessible chromosomal maternal fetus status dna indicate patau economic transcripts correlate independent anticipate trisomy women seq risk methylated abnormalities bloodstream 18 nipt m6a medical edward 13 erc sequencing discovered safer immunoprecipitation pregnant biomarkers mr proof samples prenatal generation fetal merip put tests traces limited scientific 21 nipd

Project "mR-NIPD" data sheet

The following table provides information about the project.

Coordinator	NIPD GENETICS PUBLIC COMPANY LIMITED Organization address address: NEAS EGKOMIS, 31 city: NICOSIA postcode: 2409 website: www.nipd.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Cyprus [CY]
Total cost	150˙000 €
EC max contribution	150˙000 € (100%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2015-PoC
Funding Scheme	ERC-POC
Starting year	2016
Duration (year-month-day)	from 2016-12-01 to 2018-05-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	NIPD GENETICS PUBLIC COMPANY LIMITED NIPD GENETICS PUBLIC COMPANY LIMITED Organization address address: NEAS EGKOMIS, 31 city: NICOSIA postcode: 2409 website: www.nipd.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CY (NICOSIA)	coordinator	150˙000.00

Map

Project objective

Scientific and medical evidence indicate that non-invasive prenatal testing, known as non-invasive prenatal testing (NIPT), is a safer alternative to invasive tests that might put the pregnancy at risk. Modern NIPT examine traces of fetal DNA in the maternal bloodstream to determine whether the fetus is at risk of chromosomal abnormalities such as, but not limited to, Down syndrome (trisomy 21), Patau syndrome (trisomy 13) and Edward’s syndrome (trisomy 18). In this ERC Proof of Concept Grant (mR-NIPD), we anticipate to correlate already discovered DNA biomarkers of the ERC NIPD (funded ERC) with biomarkers in mRNA transcripts. The method, directly related to the currently funded ERC, will use m6A-specific methylated mRNA immunoprecipitation combined with Next Generation Sequencing (MeRIP-Seq) on fetal and maternal mRNA samples. As a result, we aim to increase the number of fetal specific biomarkers and provide a novel, cost-effective non-invasive prenatal test that will be accessible to all pregnant women independent from social and economic status

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MR-NIPD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MR-NIPD" are provided by the European Opendata Portal: CORDIS opendata.